Drug Utilization Review (DUR) Program




The Omnibus Budget Reconciliation Act of 1990 (OBRA '90) required each state Medicaid Program to establish a Drug Utilization Review (DUR) program for outpatient drugs. The DUR program provides education to physicians, mid-level practitioners and pharmacists. This education is provided through patient profile reviews, population-based interventions, academic detailing visits and a quarterly newsletter.

By Kansas law, the DUR Board is composed of four physicians, four pharmacists and one Advanced Registered Nurse Practitioner (ARNP) or Physician’s Assistant (PA). Each appointment is for three years. The Board is responsible for implementing and operating the DUR Program and making recommendations to DHCF regarding drug therapy issues. The DUR Board meets quarterly,the third Wednesday of January, April, July, and October. All meetings are held in accordance with K.S.A. 75-4319 (Kansas Open Meetings Act)..

DUR Program Contacts:

Annette Grant, Pharmaceutical Program Manager
Division of Health Care Finance
Pharmacy Program Manager
Annette.Grant@ks.gov

Christina Faulkner, PharmD, BCPS
Clinical Pharmacist
KEPRO
391 Industry Dr
Auburn, AL 36830
office: 334.521.4714 ext. 4948
fax: 866.304.1209
www.KEPRO.com